According to Nova one advisor, the global Non-invasive Ventilators market size was valued at USD 2.9 billion in 2021 and is predicted to hit USD 3.20 billion by 2030 with a registered CAGR of 5.18% during the forecast period 2022 to 2030.
Non-invasive ventilators have become portable and more efficient to operate in different care delivery settings. Therefore, usage of non-invasive ventilators has become a preferred choice for both hospitals and patients.
Administration of ventilator support without the use of an artificial invasive airway (i.e. tracheostomy tube or endotracheal tube) is referred as non-invasive ventilation. Usage of non-invasive ventilation has increased significantly in the last two decades. Non-invasive ventilation is widely accepted for the management of both chronic and acute respiratory failure in critical care units and home care settings. Advantages offered by non-invasive ventilation over invasive ventilation include prevention of artificial airway complications, lower infection rate, reduced need of sedative medications, and lower cost.
Report Scope of the Non-invasive Ventilators Market
Report Coverage |
Details |
Market Size |
USD 3.20 Billion by 2030 |
Growth Rate |
CAGR of 5.18% from 2022 to 2030 |
Largest Market |
North America |
Fastest Growing Market |
Asia Pacific |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Product Type, Application, End-user and Region, |
Companies Mentioned |
Teleflex Incorporated, Vyaire Medical, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic plc, Koninklijke Philips N.V., Smiths Medical, ResMed, Inc., O-Two Medical Technologies Inc., Dimar s.r.l., Intersurgical Ltd., HAROL S.r.l., Vygon SA, Getinge AB, Vapotherm, Inc., and Fisher & Paykel Healthcare Limited. |
Rise in Prevalence of Chronic Obstructive Pulmonary Diseases (COPD) to Boost Market
Prevalence of COPD, asthma, and pneumonia is high across the globe. Moreover, rise in awareness and advancements in diagnostic tools are increasing the diagnostic rate of these diseases. This, in turn, is likely to propel the demand for NIV oxygen systems, such as non-invasive PPV and high flow nasal cannula O2 delivery, to treat these conditions. According to the World Health Organization (WHO), globally, 3.2 million deaths were caused by COPD in 2019. Approximately 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC). Increase in the number of tobacco smokers and rise in air pollution are likely to increase the number COPD patients. Initiatives by key players and patient associations to raise awareness about COPD is anticipated to increase the diagnosis rate of COPD. Moreover, high prevalence of the disorder across the globe and surge in the demand for COPD devices from emerging markets are likely to fuel the non-invasive ventilators market.
Increase in Geriatric Population to Propel Non-invasive Ventilators Market
Life expectancy of people has increased in the last decade. This has led to large population in the above reproducible age group. The immune system of a person weakens with age. Therefore, an increase in geriatric population has led to high risk of contracting diseases in this age group. COPD occurs most often in older people; however, it can also affect the middle-aged population.
According to the National Institute of Aging, in 2010, 8.5% of the world’s population was aged 65 years or older, which was about 525 million people. Between 2010 and 2050, the number of geriatric people in less developed countries is projected to increase by more than 250%, as compared to 71% in developed countries. Aging increases the risk of contracting respiratory diseases, which in turn is expected to boost the demand for respiratory therapeutic and diagnostic devices during the forecast period.
Increase in Demand for Homecare and Portable Non-invasive Ventilators
Demand for homecare and portable non-invasive ventilators is likely to boost the market. Furthermore, adoption of multifunctional NIV machines is on the rise in emerging markets, which is likely to further propel the non-invasive ventilators market.
Technical advancements in various non-invasive ventilation types have augmented the accuracy and reliability of these systems for diagnosis of respiratory diseases. Moreover, their extensive use in diagnosis of others diseases is likely to fuel the non-invasive ventilators market.
Technology Advancements to Boost Demand for NIV Systems Worldwide
In terms of product type, the systems segment accounted for the largest share of the market in 2021. Rise in awareness and advancements in mechanical ventilators are increasing the treatment rate of chronic respiratory diseases. This, in turn, is expected to propel the usage of latest technology ventilators. The consumables segment is likely to gain market share by the end of 2030. Key players are making significant investments to develop consumables integrated devices to avoid use of external accessories. The two segments are projected to be equally attractive during the forecast period.
Innovation and Ease of Use Drive Demand for Critical Care Non-invasive Ventilators
In terms of end-user, the critical care segment dominated the non-invasive ventilators market. Technological innovation and user-friendly approach are the two major factors that drive the demand for critical care non-invasive ventilators, particularly in the developed markets of North America and Europe. However, ease of use, versatility, and extended battery life are key benefits offered by portable non-invasive ventilators that are projected to boost the homecare settings segment during the forecast period.
Rise in Demand for COPD Devices to Fuel Market
Increase in the number of tobacco smokers, indoor air pollution, and occupational dusts, fumes and chemicals are important risk factors for COPD, are these are likely to increase the number COPD patients. Therefore, high prevalence of the COPD disorder across the globe and surge in the demand for COPD devices from emerging markets are likely to fuel the non-invasive ventilators market.
According to the WHO, COPD is the third-leading cause of death, globally, causing 3.25 million deaths in 2019. In November 2020, Philips introduced Ventilator BiPAP A40 Expiratory Flow Limitation (EFL), a noninvasive ventilator for COPD patients.
Regional Outlook of Global Non-invasive Ventilators Market
North America accounted for 35.9% of the global non-invasive ventilators market share in 2021. Supportive reimbursement policies for respiratory care, high rate of adoption of technology, and a rise in the demand for advanced ventilators for home care use contribute to the leading share held by North America in the global non-invasive ventilators market. Furthermore, surge in the number of tobacco smokers and air pollution is likely to boost the incidence of respiratory diseases and consequently propel the non-invasive ventilators market in the region.
The market in Asia Pacific is expected to rise at a high growth rate during the forecast period, due to an increase in penetration of players operating in the medical device industry in expanding markets such as China and India. Moreover, high unmet medical needs and a rise in patient awareness in Asia Pacific are expected to propel the non-invasive ventilators market in the region. Increase in awareness about respiratory diseases, improvement in health care infrastructure, rise in healthcare spending, and surge in initiatives undertaken by key players to capture the market are likely to boost the non-invasive ventilators market size in Asia Pacific.
Key Developments in Global Non-invasive Ventilators Market
Some of the prominent players in the Non-invasive Ventilators Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Non-invasive Ventilators market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders